OBIO
Orchestra BioMed Holdings, Inc.
NASDAQ · Healthcare · Biotechnology · US
$6.00
+7.91%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 745.98x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 12.26x
- Price / sales
- 11.28x
- Price / cash flow
- -6.18x
Enterprise value
- Enterprise value
- $331.5M
- EV / sales
- 10.37x
- EV / EBITDA
- -5.81x
- EV / EBIT
- -5.72x
- Market cap
- $360.6M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026